Article metrics
PDF
Other content recommended for you
- Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada
- Validation and depth evaluation of low-pass genome sequencing in prenatal diagnosis using 387 amniotic fluid samples
- The clinical significance of small copy number variants in neurodevelopmental disorders
- Exome sequencing in the assessment of congenital malformations in the fetus and neonate
- Exome sequencing as a first-tier test for copy number variant detection: retrospective evaluation and prospective screening in 2418 cases
- Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists
- Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysis
- Prenatal diagnosis of chromosomal imbalances
- Detection of copy number variants associated with late-onset conditions in ~16 200 pregnancies: parameters for disclosure and pregnancy outcome
- Exome sequencing in patients with antiepileptic drug exposure and complex phenotypes